Study Details

Clinical research studies vary based on the condition being evaluated, treatment being studied, and study requirements. Past research studies have included areas such as skin cancer, eczema, psoriasis, hair loss, dermal fillers, and more.

The goal of each study is to gather and evaluate data related to patient demographics, treatment outcomes, safety, effectiveness, and other information associated with the treatment or approach being studied.

Study duration, eligibility criteria, compensation, and participation requirements vary by trial. Depending on the study, participation may involve office visits, treatment evaluations, questionnaires, or completion of study-related materials throughout the duration of the trial. Details and requirements will be provided for each study during the screening process.

Study Details

This is a phase 2/3 randomized, double-blind, placebo-controlled study to investigate the safety and efficacy of oral investigational drug in adults with LPP. Enrolled subjects will participate in a 24-week blinded treatment period and then have the option to continue in an open label extension lasting an additional 24-weeks.

Compensation: Up to $1,125
Duration: Up to 56 weeks
Visits: 13